Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Spain
  4. Bolsas y Mercados Espanoles
  5. Laboratorios Farmaceuticos Rovi, S.A.
  6. News
  7. Summary
    ROVI   ES0157261019

LABORATORIOS FARMACEUTICOS ROVI, S.A.

(ROVI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Laboratorios Farmaceuticos Rovi S A : Spain's Rovi to Manufacture Active Ingredients for Moderna's COVID-19 Jab

04/12/2021 | 04:50am EDT


© MT Newswires 2021
All news about LABORATORIOS FARMACEUTICOS ROVI, S.A.
05/13LABORATORIOS FARMACEUTICOS ROVI S A  : First quarter 2021 results press release
PU
04/29LABORATORIOS FARMACEUTICOS ROVI S A  : Rovi To Upgrade Spanish Facility To Boost..
MT
04/29LABORATORIOS FARMACEUTICOS ROVI S A  : ROVI increases its fill-finish capacity f..
PU
04/29Moderna Announces Additional Investments To Increase Global Supply For COVID-..
RE
04/27Nestle staff sought to help Lonza production for Moderna vaccine -Swiss TV
RE
04/27REFILE-Nestle staff sought to help Lonza production for Moderna vaccine -Swis..
RE
04/16Moderna expects vaccine shipments to Britain, Canada to be delayed, EU, Swiss..
RE
04/12LABORATORIOS FARMACEUTICOS ROVI S A  : Spain's Rovi to Manufacture Active Ingred..
MT
04/12Spanish drugmaker Rovi to make ingredients for Moderna COVID-19 vaccine
RE
04/12MODERNA  : Rovi to make active agents for Moderna COVID-19 vaccine
RE
More news
Financials
Sales 2021 519 M 630 M 630 M
Net income 2021 80,6 M 97,9 M 97,9 M
Net cash 2021 16,1 M 19,6 M 19,6 M
P/E ratio 2021 37,8x
Yield 2021 0,87%
Capitalization 2 759 M 3 348 M 3 350 M
EV / Sales 2021 5,29x
EV / Sales 2022 4,25x
Nbr of Employees 1 137
Free-Float 30,6%
Chart LABORATORIOS FARMACEUTICOS ROVI, S.A.
Duration : Period :
Laboratorios Farmaceuticos Rovi, S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LABORATORIOS FARMACEUTICOS ROVI, S.A.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 52,09 €
Last Close Price 49,80 €
Spread / Highest target 21,5%
Spread / Average Target 4,60%
Spread / Lowest Target -10,0%
EPS Revisions
Managers and Directors
NameTitle
Juan López-Belmonte Encina Chief Executive Officer, Executive Director & GM
Javier López-Belmonte Encina Vice Chairman & Chief Financial Officer
Juan López-Belmonte López Chairman
Ibón Gutierro Adúriz Manager-Research & Development
José Fernando de Almansa Moreno-Barreda Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
LABORATORIOS FARMACEUTICOS ROVI, S.A.31.40%3 348
JOHNSON & JOHNSON8.16%448 257
ROCHE HOLDING AG-1.80%290 657
PFIZER, INC.8.94%224 020
ABBVIE INC.8.66%205 641
NOVARTIS AG-3.78%200 099